6622-06-6

Basic information

• Product Name: N-TERT-BUTYL-SUCCINAMIC ACID
• Synonyms: N-TERT-BUTYL-SUCCINAMIC ACID
• CAS NO: 6622-06-6
• Molecular Formula: C₈H₁₅NO₃
• Molecular Weight: 173.2096
• Mol File: 6622-06-6.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 372.4 °C at 760 mmHg
• Flash Point: 179 °C
• Appearance: /
• Density: 1.074 g/cm³
• Vapor Pressure: 1.44E-06mmHg at 25°C
• Refractive Index: 1.461
• CAS DataBase Reference: N-TERT-BUTYL-SUCCINAMIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: N-TERT-BUTYL-SUCCINAMIC ACID(6622-06-6)
• EPA Substance Registry System: N-TERT-BUTYL-SUCCINAMIC ACID(6622-06-6)

Safety Data

• Hazardous Substances Data: 6622-06-6(Hazardous Substances Data)

Usage

General Description

N-tert-butyl-succinamic acid, also known as N-TBSA, is a chemical compound with the molecular formula C10H19NO3. It is a white crystalline powder that is commonly used as a stabilizer in the synthesis of polymers and as an intermediate in the production of pharmaceuticals and agrochemicals. N-TBSA has been found to possess antioxidant and anti-inflammatory properties, and it is widely used in the food and beverage industry as a preservative to extend the shelf life of products. Additionally, it is used in personal care products and cosmetics as an emulsifier and stabilizer. Due to its versatility and beneficial properties, N-tert-butyl-succinamic acid is an important chemical in a variety of industrial applications.

InChI:InChI=1/C8H15NO3/c1-8(2,3)9-6(10)4-5-7(11)12/h4-5H2,1-3H3,(H,9,10)(H,11,12)

Upstream product

• 108-30-5 succinic acid anhydride 
• 75-64-9 tert-butylamine 
• 53242-00-5 N,O-diacetyl-N-tert-butylhydroxylamine 

Downstream Products

• 6622-05-5 1-(tert-butyl)pyrrolidine-2,5-dione 
• 192202-86-1 [(1S,2R)-1-Benzyl-3-(3-tert-butylcarbamoyl-propionylamino)-2-hydroxy-propyl]-carbamic acid tert-butyl ester 

Relevant articles and documents

Novel naphthalene-enoates: Design and anticancer activity through regulation cell autophagy

Eleven dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)naphthalene derivatives as anticancer agents through regulating cell autophagy were designed and synthesized. The anticancer activity results indicated that most compounds manifested obvious un-toxic effec

Facile syntheses and characterization of hyperbranched poly(ester-amide)s from commercially available aliphatic carboxylic anhydride and multihydroxyl primary amine

A new method for synthesis of novel hyperbranched poly(ester-amide)s from commercially available AA′ and CBx type monomers has been developed on the basis of a series of model reactions. The hyperbranched poly(ester-amide)s with multihydroxyl end groups are prepared by thermal polycondensation of carboxyl anhydrides (AA′) and multihydroxyl primary amine (CBx) without any catalyst and solvent. The reaction mechanism in the initial stage of polymerization was investigated with in situ 1H NMR. In the initial stage of the reaction, primary amino groups of 2-amino-2-ethyl-1,3-propanediol (AEPO) or tris(hydroxymethyl)aminomethane (THAM) react rapidly with anhydride, forming an intermediate which can be considered as a new ABx type monomer. Further self-polycondensation reactions of the ABx molecules produce hyperbranched polymers. Analysis using 1H and 13C NMR spectroscopy revealed the degree of branching of the resulting polymers ranging from 0.36 to 0.55. These hyperbranched poly(ester-amide)s contain configurational isomers observed by 13C and DEPT 13C NMR spectroscopy, possess high molecular weights with broad distributions and display glass-transition temperatures (Tgs) between 7 and 96°C. The thermogravimetric analytic measurements revealed the decomposition temperature at 10% weight-loss temperatures (Td10%) ranging from 212 to 325°C. Among the hyperbranched poly(ester-amide)s obtained, the polymers with cyclohexyl molecular skeleton structure exhibit the lowest branching degree, the highest glass-transition temperatures, and the best thermal stability.

MEDICINAL COMPOSITIONS CONTAINING GABAPENTIN OR PREGABALIN AND N-TYPE CALCIUM CHANNEL ANTAGONIST

The present invention relates to a pharmaceutical composition useful for preventing/treating pain, which comprises combination of gabapentin or pregabalin, or pharmaceutically acceptable salts thereof and N-type calcium channel antagonists or pharmaceutically acceptable salts thereof such as a compound having the following structure.